Loretta Gammaitoni

3.3k total citations
66 papers, 2.3k citations indexed

About

Loretta Gammaitoni is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Loretta Gammaitoni has authored 66 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 23 papers in Immunology and 18 papers in Hematology. Recurrent topics in Loretta Gammaitoni's work include CAR-T cell therapy research (23 papers), Hematopoietic Stem Cell Transplantation (15 papers) and Immune Cell Function and Interaction (15 papers). Loretta Gammaitoni is often cited by papers focused on CAR-T cell therapy research (23 papers), Hematopoietic Stem Cell Transplantation (15 papers) and Immune Cell Function and Interaction (15 papers). Loretta Gammaitoni collaborates with scholars based in Italy, United States and Belarus. Loretta Gammaitoni's co-authors include Massimo Aglietta, Franca Fagioli, Wanda Piacibello, M. C. Nucci, F Sanavio, Giuliana Cavalloni, Dario Sangiolo, Stefania Bruno, Alessandra Danè and Monica Gunetti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Loretta Gammaitoni

66 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Loretta Gammaitoni Italy 24 777 726 717 576 573 66 2.3k
Stephen J. Szilvassy United States 20 467 0.6× 904 1.2× 926 1.3× 479 0.8× 1.1k 1.9× 41 2.4k
Gian Matteo Rigolin Italy 30 710 0.9× 693 1.0× 904 1.3× 1.1k 2.0× 831 1.5× 117 2.8k
Lora W. Barsky United States 27 352 0.5× 531 0.7× 780 1.1× 340 0.6× 419 0.7× 39 2.1k
Kathryn Weibrecht United States 8 766 1.0× 805 1.1× 990 1.4× 875 1.5× 1.4k 2.5× 8 3.0k
Susan Mathew United States 24 785 1.0× 284 0.4× 1.1k 1.6× 548 1.0× 1.0k 1.7× 100 3.3k
Hiroko Hisha Japan 25 332 0.4× 601 0.8× 530 0.7× 730 1.3× 737 1.3× 65 2.1k
Naoki Hosen Japan 28 791 1.0× 871 1.2× 1.7k 2.4× 204 0.4× 659 1.2× 111 2.9k
Stefan Wöhrer Austria 26 676 0.9× 458 0.6× 695 1.0× 414 0.7× 560 1.0× 45 2.5k
Jianyu Weng China 19 507 0.7× 519 0.7× 836 1.2× 681 1.2× 406 0.7× 84 2.1k
Koichi Hattori Japan 11 626 0.8× 534 0.7× 1.0k 1.4× 541 0.9× 1.0k 1.8× 19 2.4k

Countries citing papers authored by Loretta Gammaitoni

Since Specialization
Citations

This map shows the geographic impact of Loretta Gammaitoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loretta Gammaitoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loretta Gammaitoni more than expected).

Fields of papers citing papers by Loretta Gammaitoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loretta Gammaitoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loretta Gammaitoni. The network helps show where Loretta Gammaitoni may publish in the future.

Co-authorship network of co-authors of Loretta Gammaitoni

This figure shows the co-authorship network connecting the top 25 collaborators of Loretta Gammaitoni. A scholar is included among the top collaborators of Loretta Gammaitoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loretta Gammaitoni. Loretta Gammaitoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merlano, Marco, Nerina Denaro, Danilo Galizia, et al.. (2023). Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment. Cancers. 15(21). 5257–5257. 4 indexed citations
2.
Neri, I. & Loretta Gammaitoni. (2021). Role of fluctuations in epidemic resurgence after a lockdown. Scientific Reports. 11(1). 6452–6452. 7 indexed citations
3.
Sanlorenzo, Martina, Igor Vujic, Mauro Novelli, et al.. (2018). BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti–PD-1 Antibody. Clinical Cancer Research. 24(14). 3377–3385. 30 indexed citations
4.
Peraldo‐Neia, Caterina, Giuliana Cavalloni, Elisabetta Fenocchio, et al.. (2018). Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR. PLoS ONE. 13(1). e0191593–e0191593. 13 indexed citations
5.
Sanlorenzo, Martina, Igor Vujic, Pietro Quaglino, et al.. (2015). Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectives. Expert Opinion on Biological Therapy. 15(10). 1491–1500. 6 indexed citations
6.
Leuci, Valeria, Giulia Mesiano, Loretta Gammaitoni, et al.. (2014). Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy. Anti-Cancer Agents in Medicinal Chemistry. 14(2). 211–222. 2 indexed citations
7.
Gammaitoni, Loretta, Lidia Giraudo, Valeria Leuci, et al.. (2013). Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features. Clinical Cancer Research. 19(16). 4347–4358. 80 indexed citations
8.
Pignochino, Ymera, Carmine Dell’Aglio, Marco Basiricò, et al.. (2013). The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models. Clinical Cancer Research. 19(8). 2117–2131. 91 indexed citations
9.
Cavalloni, Giuliana, Caterina Peraldo‐Neia, Ivana Sarotto, et al.. (2012). Antitumor Activity of Src Inhibitor Saracatinib (AZD-0530) in Preclinical Models of Biliary Tract Carcinomas. Molecular Cancer Therapeutics. 11(7). 1528–1538. 13 indexed citations
10.
Mesiano, Giulia, Maja Todorovic, Loretta Gammaitoni, et al.. (2012). Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. Expert Opinion on Biological Therapy. 12(6). 673–684. 122 indexed citations
11.
Valabrega, Giorgio, Giuliana Cavalloni, Gianluca Zaccarello, et al.. (2010). HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib. Breast Cancer Research and Treatment. 130(1). 29–40. 35 indexed citations
12.
13.
Cavalloni, Giuliana, Ivana Sarotto, Ymera Pignochino, et al.. (2008). Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab. Anti-Cancer Drugs. 19(7). 689–696. 7 indexed citations
14.
15.
Gammaitoni, Loretta, Stefania Bruno, F Sanavio, et al.. (2003). Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution. Experimental Hematology. 31(3). 261–270. 72 indexed citations
16.
Piacibello, Wanda, Loretta Gammaitoni, Stefania Bruno, et al.. (2000). Negative Influence of IL3 on the Expansion of Human Cord Blood In Vivo Long-Term Repopulating Stem Cells. Journal of Hematotherapy & Stem Cell Research. 9(6). 945–956. 29 indexed citations
17.
Piacibello, Wanda, Loretta Gammaitoni, Stefania Bruno, & Monica Gunetti. (2000). Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells. Stem Cells and Development. 9. 45–56. 1 indexed citations
18.
Piacibello, Wanda, F Sanavio, A Severino, et al.. (1998). Ex Vivo Expansion of Cord Blood Progenitors. Vox Sanguinis. 74(S2). 457–462. 13 indexed citations
19.
Piacibello, Wanda, F Sanavio, L. Garetto, et al.. (1998). Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia. 12(5). 718–727. 111 indexed citations
20.
Avanzi, G., Margherita Gallicchio, Giuliana Cavalloni, et al.. (1997). GAS6, the ligand of Axl and Rse receptors, is expressed in hematopoietic tissue but lacks mitogenic activity.. PubMed. 25(12). 1219–26. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen J. Szilvassy Breakdown of academic impact, for papers by Gian Matteo Rigolin Breakdown of academic impact, for papers by Lora W. Barsky Breakdown of academic impact, for papers by Kathryn Weibrecht Breakdown of academic impact, for papers by Susan Mathew Breakdown of academic impact, for papers by Hiroko Hisha Breakdown of academic impact, for papers by Naoki Hosen Breakdown of academic impact, for papers by Stefan Wöhrer Breakdown of academic impact, for papers by Jianyu Weng Breakdown of academic impact, for papers by Koichi Hattori
Rankless by CCL
2026